Loading...
NPI 1124409958 · Alpharetta, GA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Chattahoochee Physicians Laboratory Services, LLC is a clinical medical laboratory provider located in Alpharetta, Georgia. This profile covers 31 Medicare and 75 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Chattahoochee Physicians Laboratory Services, LLC |
| Address | 1122 Cambridge Sq |
| City | Alpharetta |
| State | GA |
| ZIP | 30009 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 17, 2015 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $810.5K |
| Medicare | $388.1K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
31 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,260 | $240 | $304.4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 700 | $60 | $42.9K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 70 | $200 | $13.8K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 2,620 | $10 | $13.1K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 20 | $150 | $3.4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 20 | $110 | $1.7K |
| 82785 | The lab analyst performs the technical lab test to analyze the quantity of immunoglobulin E in the specimen. | 50 | $20 | $740 |
| 82670 | The lab analyst measures the level of total estradiol, an estrogenic hormone, on a specimen such as blood using a method such as liquid chromatography–tandem mass spectrometry (LC–MS/MS) to evaluate… | 20 | $30 | $540 |
| 84402 | The lab analyst performs a test to measure free testosterone, typically in patient serum. | 20 | $30 | $500 |
| 84403 | The lab analyst performs a test to measure total testosterone, typically in patient serum. | 20 | $30 | $500 |
Showing 1–10 of 31
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 31 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
31 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0483 | 4 | 60 | 120 | $240 | $99.9K |
| 86003 | 5 | 10 | 7,080 | $10 | $71.2K |
| G0480 | 103 | 110 | 90 | $110 | $48.1K |
| G0482 | 41 | 80 | 70 | $190 | $36.8K |
| G0481 | 99 | 120 | 80 | $150 | $36.5K |
| 82088 | 2 | 10 | 820 | $40 | $32.9K |
| 80307 | 24 | 210 | 210 | $60 | $28.5K |
| 82627 | 4 | 10 | 90 | $20 | $18.4K |
| 82670 | 9 | 10 | 50 | $30 | $18.1K |
| 84140 | 2 | 10 | 690 | $20 | $13.9K |
Showing 1–10 of 31
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
75 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 7,320 | $70 | $498K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 6,940 | $30 | $180.5K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 330 | $160 | $53.4K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 340 | $30 | $9.5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 120 | $80 | $9.4K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 170 | $60 | $9.1K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 540 | $10 | $7.5K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 30 | $160 | $5.1K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 110 | $20 | $2.2K |
| 87640 | The lab analyst performs the technical lab test to look for Staphylococcus aureus nucleic acid using an amplified probe technique. | 340 | $10 | $2K |
Showing 1–10 of 75
How this provider's Medicaid billing volume and revenue compare to other Georgia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Georgia median
75 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 10 | 30 | 2,370 | $100 | $757.4K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 8 | 10 | 900 | $40 | $638.4K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 17 | 30 | 860 | $70 | $525.3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 26 | 30 | 940 | $30 | $467.9K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 23 | 70 | 2,840 | $30 | $428.7K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 20 | 30 | 1,130 | $50 | $338.3K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 30 | 40 | 1,100 | $20 | $287.1K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 29 | 40 | 1,160 | $20 | $275.9K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 18 | 20 | 430 | $90 | $241.3K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 22 | 40 | 180 | $20 | $194.3K |
Showing 1–10 of 75
Other providers in the same ZIP code as Chattahoochee Physicians Laboratory Services, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Public Partnerships LLC | GA | Supports Brokerage Agency | $0 | $522.8M |
| Public Partnerships LLC | GA | Supports Brokerage Agency | $0 | $7.2M |
| Milton Hall Surgical Associates, LLC | GA | Specialist | $0 | $3.8M |
| Robert S. Smith Md, Inc | GA | Anatomic Pathology & Clinical Pathology Physician | $0 | $3.5M |
| Public Partnerships LLC | GA | In Home Supportive Care Agency | $0 | $3.1M |
| Jeremy Alexander | GA | General Practice Dentistry | $0 | $1.7M |
| Laura Michael | GA | Anatomic Pathology Physician | $1.3M | $71.5K |
| A Smile 4 U | GA | General Practice Dentistry | $0 | $1.1M |
| Kishore Rasamallu | GA | Internal Medicine Physician | $1M | $0 |
| Tara Chang | GA | Anatomic Pathology & Clinical Pathology Physician | $325.1K | $28.9K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.